ECM
LNAI

ExodusPoint Capital Management’s Lunai Bioworks LNAI Stock Holding History

ExodusPoint Capital Management’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-151
Closed -$3K – 1957
2025
Q2 		$3K Buy
+151
New +$4.22K ﹤0.01% 1405
2024
Q2 		– Sell
-735
Closed -$156K – 1923
2024
Q1 		$156K Buy
735
+423
+136% +$114K ﹤0.01% 1384
2023
Q4 		$79K Buy
+312
New +$85.5K ﹤0.01% 1368
2022
Q2 		– Sell
-639
Closed -$422K – 2365
2022
Q1 		$422K Sell
639
-26
-4% -$13.8K 0.01% 1630
2021
Q4 		$388K Buy
+665
New +$483K ﹤0.01% 1545
2019
Q2 		– Sell
-409
Closed -$227K – 1297
2019
Q1 		$227K Buy
+409
New +$239K 0.02% 529

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return